Filing Details
- Accession Number:
- 0001127602-11-032979
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-21 11:14:32
- Reporting Period:
- 2011-12-20
- Filing Date:
- 2011-12-21
- Accepted Time:
- 2011-12-21 11:14:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263230 | J Robert Perez | 65 Hayden Avenue Lexington MA 02421 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-20 | 25,000 | $13.25 | 49,893 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-20 | 25,000 | $39.48 | 24,893 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-12-20 | 25,000 | $0.00 | 25,000 | $13.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 31,000 | 2003-12-02 | 2013-09-02 | No | 4 | M | Direct |
Footnotes
- Exercised pursuant to a Rule 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $39.4800 to $39.5100. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
